Dare Bioscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 94.7% | 94.7% | -1,507.8% |
| FY2017 | -86.5% | -86.5% | -80.7% |
| FY2018 | -248.8% | -248.8% | -213.8% |
| FY2019 | -3,235.7% | -3,235.7% | -191.6% |
| FY2020 | 2,379.1% | 2,379.1% | -362.9% |
| FY2021 | -99.8% | -99.8% | -69.3% |
| FY2022 | -278.5% | -278.5% | -70.6% |
| FY2023 | 597.5% | 597.5% | -141.7% |
| FY2024 | 67.4% | 67.4% | -18.3% |
| FY2025 | -471.4% | -471.4% | -41.3% |